5 ML zoledronic acid 0.8 MG/ML Injection [Zometa]
Semantic Scholar uses AI to extract papers important to this topic.
Patients with solid cancer frequently develop bone metastases (BM). Zoledronic acid (Zometa®, ZA), routinely used to treat… Expand BACKGROUND
The extracellular matrix (ECM) components play key roles in the multistep process of cancer growth and progression… Expand SummaryAbstractZoledronic acid (Zometa®1) is an effective inhibitor of osteoclast-mediated bone resorption. Zoledronic acid… Expand SummaryAbstractZoledronic acid (Zometa®), a third-generation amino-bisphosphonate, has been approved in the US, the EU and many… Expand Bisphosphonates are widely used as therapeutic agents in bone disorders including cancer metastasis due to their osteoclast… Expand Zoledronic acid (ZA; Zometa®) is a cyclic nitrogen-containing bisphosphonate with anti-tumor activity used to treat patients with… Expand Pamidronate (PAM) and zoledronic acid (ZOL) are aminobisphosphonates (BPs) able to affect the isoprenylation of intracellular… Expand AbstractZoledronic acid (Zometa®) is an effective inhibitor of osteoclast-mediated bone resorption. Zoledronic acid demonstrated… Expand Summary This report summarises the results of the clinical development program of zoledronic acid (Zometa ® ), a third generation… Expand Metastatic bone disease develops as a result of the many interactions between tumour cells and bone cells. This leads to… Expand